ANSWER is committed to advancing intellectual property (IP) policy reforms to enhance access to essential medicines. The organization works to ensure that people living with HIV and other health conditions benefit from fairer IP regulations and improved treatment accessibility.
ANSWER is ITPC EECA’s partner in Kazakhstan and has substantial IP expertise, actively contributing to intellectual property policy reforms in the country.
ANSWER has successfully managed the inclusion of a government-use license in Kazakhstan’s National Strategy for IP Development (2021-2025), marking a significant step toward improving access to essential medicines. The organization has positioned itself as a key player in IP-related advocacy and policy reform and is well-placed to drive further advancements in the coming years.